Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-R-4828 | Fanotaprim CAS No.2120282-75-7 | Fanotaprim/CAS No.2120282-75-7 is a dihydrofolate reductase (DHFR) inhibitor with IC50s of 1.57 and 308 nM for tgDHFR (Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. Fanotaprim has the potential for the research of toxoplasmosis. | price> |
R-C-3159 | CGP-42112 CAS:127060-75-7 | CGP-42112(CGP-42112A) is a potent Angiotensin-II subtype 2 receptor(AT2 R) agonist. | price> |
R-R-4829 | Cycloguanil-d6 | Cycloguanil-d66 is the deuterium labeled Cycloguanil, which is a dihydrofolate reductase inhibitor. | price> |
R-C-3160 | AVE 0991 CAS:304462-19-9 | AVE 0991 is a nonpeptide and orally active angiotensin-(1-7)receptor agonist with an IC50 of 21nM. | price> |
R-R-4830 | Trimethoprim-d3 CAS No.1189923-38-3 | Trimethoprim-d3/CAS No.1189923-38-3 is the deuterium labeled Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for urinary tract infections, Shigellosis and Pneumocystis pneumonia treatment. | price> |
R-C-3161 | SR-12813 CAS:126411-39-0 | SR-12813 is a pregnane X receptor(PXR)agonist and HMG-CoA reductase inhibitor with an IC50 of 850 nM. | price> |
R-R-4831 | Proguanil-d6 hydrochloride | Proguanil-d6 hydrochloride is the deuterium labeled Proguanil hydrochloride (HY-B0806A). Proguanil hydrochloride, an antimalarial proagent, is metabolized to the active metabolite Cycloguanil (HY-12784). Proguanil hydrochloride is a dihydrofolate reductase (DHFR) inhibitor. | price> |
R-C-3162 | Epristeride CAS:119169-78-7 | Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2. | price> |
R-R-4832 | Viltolarsen sodium | Viltolarsen (NS-065/NCNP-01) sodium is a phosphorodiamidate morpholino antisense oligonucleotide. Viltolarsen sodium binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. Viltolarsen sodium has the potential for Duchenne muscular dystrophy (DMD) research. | price> |
R-C-3163 | AR-231453 CAS:733750-99-7 | AR-231453 is a potent and selective small molecule agonis of GPR119 that enhances glucose dependent insulin secretion and glucagon like peptide-1 (GLP-1) release. | price> |
R-R-4833 | DMTr-5-fluoro-2-deoxycytidine-phosphoramidite CAS No.143774-48-5 | DMTr-5-fluoro-2-deoxycytidine-phosphoramidite (compound 1B)/CAS No.143774-48-5 is a phosphoramidite of 5-Fluoro-2-deoxycytidine. | price> |
R-C-3164 | 6-OAU CAS:83797-69-7 | 6-OAU (GTPL5846, 6-n-octylaminouracil) is a surrogate agonist of G protein-coupled receptor 84 (GPR84) that activates human GPR84 in the presence of Gqi5 chimera in HEK293 cells with EC50 of 105 nM in the PI assay.6-OAU(GTPL5846,6-n-octylaminouracil)increases [35S]GTPγS incorporated in Sf9 cell membranes expressing human GPR84-Gαi fusion protein with EC50 of 512nM. | price> |
R-R-4834 | Trifluridine/tipiracil hydrochloride mixture CAS No.733030-01-8 | Trifluridine/tipiracil hydrochloride mixture (TAS-102)/CAS No.733030-01-8 is a potent and orally active nucleoside antitumor agent. The composition of Trifluridine/tipiracil hydrochloride mixture (TAS-102) is a 1:0.5 mixture (on a molar basis) of alpha,alpha,alpha-tri-fluorothymidine (FTD) and thymidine phosphorylase inhibitor (TPI). Trifluridine/tipiracil hydrochloride mixture (TAS-102) shows the antitumor activity mainly via the inhibition of thymidylate synthase (TS) and incorporation into DNA. | price> |
R-C-3165 | Versipelostatin | Versipelostatin is a novel GRP78/Bip molecular chaperone down-regulator of microbial origin that was isolated from the metabolite of Streptomyces versipellis strain 4083-SVS6.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4835 | 2-Chloroadenosine CAS No.146-77-0 | 2-Chloroadenosine/CAS No.146-77-0, a stable adenosine analogue, protects against long term development of ischaemic cell loss in the rat hippocampus. 2-Chloroadenosine is an apparent competitive inhibitor of uridine influx (apparent Ki=33 μM) and high-affinity nitrobenzylthioinosine binding (apparent Ki=0.18 mM). 2-Chloroadenosine is a transported permeant for the nucleoside transporter in human erythrocytes. | price> |
R-R-4836 | 7-Methylguanosine CAS No.20244-86-4 | 7-Methylguanosine/CAS No.20244-86-4 is a novel cNIIIB nucleotidase inhibitor with IC50 value of 87.8 ± 7.5 µM. | price> |
R-C-3167 | NCRW0005-F05 CAS:342779-66-2 | NCRW0005-F05, first antagonist selective for GPR139 (IC50 value 0.21 uM); a useful tool to study GPR139 pharmacology, especially in combination with the GPR139 agonist JNJ 63533054.Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4837 | Sangivamycin CAS No.18417-89-5 | Sangivamycin (NSC 65346)/CAS No.18417-89-5, a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers. | price> |
R-C-3168 | BMS-564929 CAS:627530-84-1 | BMS-564929 is a novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator, and this compound has been advanced to clinical trials for the treatment of age-related functional decline. Our products are only suitable for scientific research experiments, not for clinical experiments and human body. | price> |
R-R-4838 | 3-Methylcytidine CAS No.2140-64-9 | 3-Methylcytidine/CAS No.2140-64-9, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. | price> |